Testosterone, cardiovascular disease and the metabolic syndrome.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Best practice & research. Clinical endocrinology & metabolism

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.beem.2010.07.002PMID 21397202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Testosterone and metabolic syndrome: a meta-analysis study.

  2011cited by this paper
• Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction.

  2011cited by this paper
• Metabolic Syndrome and Erectile Dysfunction

  2011cited by this paper
• Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.

  2010cited by this paper
• Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction.

  2010cited by this paper
• Monocytes in atherosclerosis: subsets and functions

  2010cited by this paper
• Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?

  2010cited by this paper
• Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors.

  2010cited by this paper
• Testosterone and heart failure

  2010cited by this paper
• Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.

  2010cited by this paper
• Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.

  2010cited by this paper
• Sex steroid hormone concentrations and risk of death in US men.

  2010cited by this paper
• Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome

  2010cited by this paper
• Psychobiological correlates of women's sexual interest as perceived by patients with erectile dysfunction.

  2010cited by this paper
• The Moscow study: a randomized, placebo-controlled, double-blind trial of parenteral testosterone undecanoate on the metabolic syndrome components and body composition

  2010cited by this paper
• Effects of Testosterone Undecanoate on Cardiovascular Risk Factors and Atherosclerosis in Middle-Aged Men with Late-Onset Hypogonadism and Metabolic Syndrome : Results from a 24-month , Randomized , Double-Blind , Placebo-Controlled Studyjsm

  2010cited by this paper
• A sex-specific role for androgens in angiogenesis

  2010cited by this paper
• Androgen Receptor-dependent Transactivation of Growth Arrest-specific Gene 6 Mediates Inhibitory Effects of Testosterone on Vascular Calcification*

  2010cited by this paper
• Androgen‐suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke

  2010cited by this paper
• ORIGINAL RESEARCH—ERECTILE DYSFUNCTION Severe Depressive Symptoms and Cardiovascular Risk in Subjects with Erectile Dysfunction

  2010cited by this paper
• Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/akt pathway.

  2010cited by this paper
• Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome.

  2010cited by this paper
• Testosterone deficiency: a risk factor for cardiovascular disease?

  2010cited by this paper
• Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction.

  2010cited by this paper
• Association between metabolic syndrome or its components and asymptomatic cardiovascular disease in the RIVANA-study.

  2010cited by this paper
• Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Priapus is happier with Venus than with Bacchus.

  2010cited by this paper
• Identification of late-onset hypogonadism in middle-aged and elderly men.

  2010cited by this paper
• Adverse events associated with testosterone administration.

  2010cited by this paper
• Low free testosterone predicts frailty in older men: the health in men study.

  2010cited by this paper
• Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older men.

  2010cited by this paper
• Testosterone Deficiency and Exercise Intolerance in Heart Failure: Treatment Implications

  2010cited by this paper
• Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

  2009cited by this paper
• Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED.

  2009cited by this paper
• Gender differences in the cardiovascular effect of sex hormones

  2009cited by this paper
• Reduced testosterone levels in males with lone atrial fibrillation

  2009cited by this paper
• Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine.

  2009cited by this paper
• Heart failure as a multiple hormonal deficiency syndrome.

  2009cited by this paper
• Low serum testosterone and estradiol predict mortality in elderly men.

  2009cited by this paper
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

  2009cited by this paper
• cardiovascular disease and mortality in men. The Tromsø Study.

  2009cited by this paper
• Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men.

  2009cited by this paper
• Lower testosterone levels predict incident stroke and transient ischemic attack in older men.

  2009cited by this paper
• Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.

  2009cited by this paper
• Low circulating androgens and mortality risk in heart failure

  2009cited by this paper
• Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome.

  2009cited by this paper
• Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment

  2009cited by this paper
• Testosterone: a novel therapeutic approach in chronic heart failure?

  2009cited by this paper
• Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome

  2008cited by this paper
• The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.

  2008cited by this paper
• Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

  2008cited by this paper
• Low serum testosterone and mortality in older men.

  2008cited by this paper
• Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.

  2008cited by this paper
• Low levels of androgens in men with erectile dysfunction and obesity.

  2008cited by this paper
• Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

  2008cited by this paper
• Effects of Oral Testosterone Treatment on Myocardial Perfusion and Vascular Function in Men With Low Plasma Testosterone and Coronary Heart Disease

  2008cited by this paper
• Serum estradiol and risk of stroke in elderly men

  2007cited by this paper
• Physiological Testosterone Replacement Therapy Attenuates Fatty Streak Formation and Improves High-Density Lipoprotein Cholesterol in the Tfm Mouse: An Effect That Is Independent of the Classic Androgen Receptor

  2007cited by this paper
• Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

  2007cited by this paper
• Low testosterone levels are associated with coronary artery disease in male patients with angina

  2007cited by this paper
• Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study.

  2007cited by this paper
• Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

  2007cited by this paper
• Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

  2007cited by this paper
• Sex steroids and all-cause and cause-specific mortality in men.

  2007cited by this paper
• Molecular requirements for L-type Ca2+ channel blockade by testosterone.

  2007cited by this paper
• The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact.

  2007cited by this paper
• Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.

  2007cited by this paper
• Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus.

  2007cited by this paper
• Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells.

  2007cited by this paper
• Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.

  2007cited by this paper
• Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.

  2006cited by this paper
• Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.

  2006cited by this paper
• Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements.

  2006cited by this paper
• Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

  2006cited by this paper
• Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men

  2006cited by this paper
• Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival

  2006cited by this paper
• Low serum testosterone and mortality in male veterans.

  2006cited by this paper
• Androgen Treatment and Muscle Strength in Elderly Men: A Meta‐Analysis

  2006cited by this paper
• Reduced number of circulating endothelial progenitor cells in hypogonadal men.

  2006cited by this paper
• Abstract 4185: Low Testosterone Level is an Independent Determinant of Endothelial Dysfunction in Men

  2006cited by this paper
• The third analysis of the bicalutamide Early Prostate Cancer programme

  2006cited by this paper
• Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.

  2006cited by this paper
• Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.

  2006cited by this paper
• PKCδ Mediates Testosterone-induced Increases in Coronary Smooth Muscle Cav1.2*

  2005cited by this paper
• Increased carotid atherosclerosis in andropausal middle-aged men.

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy.

  2005cited by this paper
• Cortisol, Testosterone, and Coronary Heart Disease: Prospective Evidence From the Caerphilly Study

  2005cited by this paper
• Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

  2005cited by this paper
• Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.

  2005cited by this paper
• PKCdelta mediates testosterone-induced increases in coronary smooth muscle Cav1.2.

  2005cited by this paper
• Effects of testosterone on sexual function in men: results of a meta‐analysis

  2005cited by this paper
• The metabolic syndrome--a new worldwide definition.

  2005cited by this paper
• Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa.

  2004cited by this paper
• Endogenous testosterone increases L-type Ca2+ channel expression in porcine coronary smooth muscle.

  2004cited by this paper
• Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life

  2004cited by this paper
• Testosterone treatment for men with chronic heart failure

  2004cited by this paper

• Investigation of the effect of cardiorespiratory fitness on cardiometabolic risk factors and testosterone levels in firefighters

  2025cites this paper
• Endogenous Sex Steroid Hormones, Sex Hormone-Binding Globulin, and Risk of All-Cause and Cause-Specific Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies

  2025cites this paper
• Effects of Testosterone Deficiency and Therapy on the Cardiometabolic Syndrome in Men.

  2025cites this paper
• The contribution of prolactin in the occurrence of premature cardiovascular disease predominantly through modulating the inflammatory cascade

  2025cites this paper
• Testosterone is positively associated with coronary artery calcium in a low cardiovascular disease risk population

  2023cites this paper
• Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men

  2023cites this paper
• Male sex hormones, aging, and inflammation

  2023cites this paper
• Cardiovascular mortality post burn injury

  2022cites this paper
• Testosterone, Hypogonadism, and Heart Failure

  2022cites this paper
• Androgenic steroids dysregulation and the risk of coronary artery disease

  2022cites this paper
• Serum testosterone mirrors inflammation parameters in females hospitalized with COVID-19

  2022cites this paper
• Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men

  2021cites this paper
• Prediction of secondary testosterone deficiency using machine learning: A comparative analysis of ensemble and base classifiers, probability calibration, and sampling strategies in a slightly imbalanced dataset

  2021cites this paper
• Sex-Steroid Signaling in Lung Diseases and Inflammation.

  2021cites this paper
• Metabolic Syndrome and Reproduction

  2021cites this paper
• Local and Systemic Complications of Local Testosterone Patches and Gels

  2021cites this paper
• Metabolic syndrome and male lower urinary tract symptoms.

  2021cites this paper
• Genetic Factors of Non-Obstructive Azoospermia: Consequences on Patients’ and Offspring Health

  2021cites this paper
• Testicular involvement is a hallmark of Apo A-I Leu75Pro mutation amyloidosis.

  2020cites this paper
• Effects of Testosterone Therapy on Erythrocytosis and Prostate Adverse Events in Obese Males with Functional Hypogonadism and Type 2 Diabetes in a 2-Year Clinical Trial

  2020cites this paper
• Independent Association of Erectile Dysfunction and Low Testosterone Levels With Life Dissatisfaction in Men With Chronic Spinal Cord Injury.

  2020cites this paper
• Testosterone, HIV, and cardiovascular disease risk

  2020cites this paper
• Androgen-Regulated Cardiac Metabolism in Aging Men

  2020cites this paper
• Metabolic syndrome and chronic prostatitis

  2020cites this paper
• Icariin modulates eNOS activity via effect on post‐translational protein‐protein interactions to improve erectile function of spontaneously hypertensive rats

  2020cites this paper
• Relationship of Vitamin D status with testosterone levels: a systematic review and meta-analysis

  2020cites this paper
• Testosterone and Men's Health

  2019cites this paper
• Cardiovascular Disease and Men's Health

  2019cites this paper
• The Impact of Metabolic Syndrome and Its Components on Female Sexual Dysfunction: A Narrative Mini-Review

  2019cites this paper
• Sperm Count and Hypogonadism as Markers of General Male Health.

  2019cites this paper
• Vascular Pathways of Testosterone: Clinical Implications

  2019cites this paper
• Impact of androgen action on reproduction and cardiovascular disease in male cancer survivors

  2018cites this paper
• Administration of testosterone improves the prothrombotic and antifibrinolytic parameters associated with its deficiency in an orchidectiomized rat model.

  2018cites this paper
• Obesity and Aging in Late-Onset Hypogonadism

  2017cites this paper
• Effect of testosterone replacement therapy on vitamin D and FGF-23 levels in congenital hypogonadism.

  2017cites this paper
• Treatment of Hypogonadism

  2017cites this paper
• Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis

  2017cites this paper
• Cardiovascular risk profile in burn survivors.

  2017cites this paper
• Testosterone treatment and cardiovascular events in prescription database studies

  2017cites this paper
• The Role of Some Hormone Levels and Histopathological Changes in Thyroid Gland and Testes in Experimentally Induced Myocardial Infraction in Male Rats

  2017cites this paper
• Effect of the conditioned medium from H9C2 cell line treated with dehydroepiandrosterone and exposed to damage on the motility of mesenchymal stem cells

  2017cites this paper
• Efecto del Medio Condicionado de la Línea Celular H9C2 Tratada con Dehidroepiandrosterona y Expuesta a Daño sobre la Motilidad de Células Troncales Mesenquimales

  2017cites this paper
• British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice.

  2017cites this paper
• Hypogonadism in Systemic Diseases

  2017cites this paper
• Late-onset hypogonadism

  2017cites this paper
• Hypocholesterolemic efficacy of royal jelly in healthy mild hypercholesterolemic adults

  2016cites this paper
• Testosterone and Voluntary Exercise, Alone or Together Increase Cardiac Activation of AKT and ERK1/2 in Diabetic Rats

  2016cites this paper
• Hypogonadism: The Relationship to Cardiometabolic Syndrome and the Controversy Behind Testosterone Replacement Therapy

  2016cites this paper
• Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury

  2016cites this paper
• Off label therapies for testosterone replacement

  2016cites this paper
• Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.

  2016cites this paper
• Risk Factors for Hypogonadism in Male Patients with Type 2 Diabetes

  2016cites this paper
• Prevalence of Low Serum Testosterone among Type 2 Diabetes Mellitus: A Predictor of Micro Vascular Disease

  2015cites this paper
• Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men

  2015cites this paper
• Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes

  2015cites this paper
• Testosterone and metabolic syndrome

  2015cites this paper
• Should Family Physicians Screen for Testosterone Deficiency in Men? Editorials: Controversies in Family Medicine

  2015cites this paper
• Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes

  2015cites this paper
• Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis

  2015cites this paper
• Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study

  2015influential citation
• Should family physicians screen for testosterone deficiency in men? Yes: screening for testosterone deficiency is worthwhile for most older men.

  2015cites this paper
• Differential effects of strength training and testosterone treatment on soluble CD36 in aging men: Possible relation to changes in body composition

  2015cites this paper
• Androgens in cardiac fibrosis and other cardiovascular mechanisms.

  2015cites this paper
• Testosterone and cardiovascular disease – the controversy and the facts

  2015cites this paper
• Update on Testosterone Replacement Therapy in Hypogonadal Men

  2015cites this paper
• Can testosterone level be a good predictor of late‐onset hypogonadism?

  2015cites this paper
• [The "obese" and "old" male patient in dermatological practice. When should hypogonadism be considered?].

  2015cites this paper
• Der „dicke“ und der „alte“ Patient in der dermatologischen Praxis

  2015cites this paper
• Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia.

  2015cites this paper
• Metabolic syndrome and benign prostatic enlargement: a systematic review and meta‐analysis

  2015cites this paper
• Prevalencia del síndrome de déficit de testosterona entre varones con disfunción sexual: de la sospecha a la realidad. Un estudio descriptivo transversal

  2014cites this paper
• Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

  2014cites this paper
• Patient satisfaction with testosterone replacement therapies: the reasons behind the choices.

  2014cites this paper
• Marked testosterone deficiency-related symptoms may be associated to higher metabolic risk in men with low testosterone levels.

  2014cites this paper
• Wasting syndrome with deep bradycardia as presenting manifestation of long-standing severe male hypogonadotropic hypogonadism: a case series

  2014cites this paper
• Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.

  2014influential citation
• Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden.

  2014cites this paper
• Opposite effects of tamoxifen on metabolic syndrome‐induced bladder and prostate alterations: A role for GPR30/GPER?

  2014cites this paper
• Adverse effects of testosterone replacement therapy: an update on the evidence and controversy

  2014cites this paper
• Death by testosterone? We think not!

  2014cites this paper
• Erectile dysfunction and central obesity: an Italian perspective

  2014cites this paper
• Metabolic syndrome and prostate abnormalities in male subjects of infertile couples

  2014cites this paper
• Testosterone, aging and survival: biomarker or deficiency

  2014cites this paper
• Correlates of low testosterone in men with chronic spinal cord injury

  2014cites this paper
• Re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et Al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur urol 2014;65:968-78.

  2014cites this paper
• The relationship between testosterone, metabolic syndrome, and mean carotid intima-media thickness in aging men

  2014cites this paper
• Impact of Metabolic Syndrome on Benign Prostatic Hyperplasia in Elderly Chinese Men

  2014cites this paper
• Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events

  2014influential citation
• Risk factors for eosinophilic esophagitis

  2014cites this paper
• The Effect of Testosterone on Cardiovascular Disease

  2014cites this paper
• Characteristics of compensated hypogonadism in patients with sexual dysfunction.

  2014cites this paper
• Bone benefits of testosterone replacement therapy in male hypogonadism.

  2014cites this paper
• Outcomes of testosterone therapy in men with testosterone deficiency (TD): part II.

  2014cites this paper
• Testosterone levels and heart failure in obese and non-obese men.

  2014cites this paper
• Reply to Christopher Chee Kong Ho, Siew Eng Ho, Srijit Das' letter to the editor re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol 2014;65:968-78.

  2014cites this paper
• Late Effects in Testicular Cancer Survivors

  2014cites this paper
• Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions

  2014cites this paper
• Influence de la testostérone sur les paramètres électrocardiographiques des hommes et des femmes

  2014cites this paper
• Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS).

  2014cites this paper
• Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors.

  2014cites this paper